monoclonal antibodies (mAbs)

monoclonal antibodies (mAbs)

featured image of Revolutionizing Monoclonal Antibody Production with AI!

Revolutionizing Monoclonal Antibody Production with AI!

BIOT

🌟 Discover how continuous monoclonal antibody processing connects 60+ stakeholders! 🤝 Explore real-time deviations, automation, and AI's role in quality assurance. 🧬🔧

featured image of Revolutionary AI Model Transforms Drug Development Confidentially!

Revolutionary AI Model Transforms Drug Development Confidentially!

BIOT

Unlocking drug development! 🧪 New Jersey researchers built a model to estimate antibody viscosity while keeping data confidential. 🔒✨ DeepLearning

featured image of Defense Department Chooses Just - Evotec for Biomanufacturing Breakthrough

Defense Department Chooses Just – Evotec for Biomanufacturing Breakthrough

BIOT

📢 The U.S. Department of Defense selects Just - Evotec Biologics for biomanufacturing optimization! 💼💲🔬✅ $39 million program to enhance rapid response capabilities.

featured image of Transgenic Goats: The Solution to South Africa's Drug Shortages?

Transgenic Goats: The Solution to South Africa’s Drug Shortages?

BIOT

🔍 South Africa partners with Bio-Sourcing and Afrigen Biologics to use transgenic goats for affordable medicines. 🐐👩‍⚕️💡🌍

featured image of Game-Changing VHH Proteins: Threatening Monoclonal Antibodies?

Game-Changing VHH Proteins: Threatening Monoclonal Antibodies?

BIOT

🔍 VHH proteins could challenge monoclonal antibodies. 💡 They are smaller, simpler, and cheaper, offering advantages in certain applications. 💰💊💪🌍

featured image of Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies

Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies

BIOT

🔍 Monoclonal antibodies (mAbs) have paved the way for advanced therapies, thanks to decades of development and manufacturing improvements. 💪

featured image of Discover the Game-Changing Modulator for Antibodies

Discover the Game-Changing Modulator for Antibodies

BIOT

🔍 Scientists discovered a new modulator, maduramycin, that enhances M5 glycans in monoclonal antibodies (mAbs). 🧪👩‍🔬 🔬 Maduramycin offers an alternative to existing modulators for subcutaneously-administered biologics. 💉 🔬 The combination of maduramycin and kifunensine allows control over high-mannose distribution in manufacturing processes. 💪

featured image of Revolutionary Partnership: Purolite and Repligen Transform mAbs Purification Process

Revolutionary Partnership: Purolite and Repligen Transform mAbs Purification Process

BIOT

💡 Purolite and Repligen collaborate on advanced chromatography resins for efficient purification of mAbs in biopharmaceutical production.🔬💉